🔴 NRX Pharmaceuticals Inc is trading 23.8% down today on a proposed public offering of common stock

NRX Pharmaceuticals Inc is trading 23.8% down at $3.52 after disclosing a proposed underwritten public offering of common stock.

• The stock previously fell 19.05% to $3.74 in after-hours trading on June 2, with the decline extending into pre-market sessions as investors react to potential dilution.
• While the offering is intended to raise funds for working capital and general corporate purposes, the market is treating the move as an immediate overhang on existing shareholders.
• The price movement is being driven by company-specific financing news rather than broader market trends.